A randomized double-blind placebo-controlled multicenter trial assessing the impact of lipoprotein(a) lowering with TQJ230 on major cardiovascular events in patients with established cardiovascular disease



If you are registered as a volunteer, please log in to contact the study team/express interest in this study.